← Leaderboards
Kristen Leanne Zuloaga
Oregon Health & Science University
$5,438,712
Attributed
$12,298,931
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2012–25$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,298,931 · 4
By mechanism
U01$8,232,263 · 1
R01$3,445,207 · 1
R21$462,923 · 1
F32$158,538 · 1
Top collaborators
- Oscar Harari8 shared
- Martin Kampmann8 shared
- Celeste Marie Karch8 shared
- Kevin M Pumiglia8 shared
- Sally Temple8 shared
Most similar at Oregon Health & Science University
Same institution · by research overlap
- Marina Elizabeth Wolf$19,441,692
- Marina Guizzetti$8,598,193
- Anusha Mishra$3,703,227
- Simone Woodruff$108,512
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposWomanEndotheliumProductionPerfusionCerebrumDementiaBrainBlood VesselsPathologyCellsBrain Endothelial CellCognitive FunctionEndothelial CellsIn VivoMouse ModelBlood - Brain Barrier AnatomyImpairmentMetabolic DiseasesFemaleDementia RiskMenopauseLinkEstradiol
Grant awards (20)
Investigating the Functional Impact of AD Risk Genes on Neuro-Vascular Interactions$1,514,673
U01 · FY2025 · AG
Metabolic and Hormonal Mechanisms of VCID$813,675
R01 · FY2025 · NS · contact PI
Investigating the Functional Impact of AD Risk Genes on Neuro-Vascular Interactions$1,573,956
U01 · FY2024 · AG
Metabolic and Hormonal Mechanisms of VCID$828,967
R01 · FY2024 · NS · contact PI
Developing new mouse models of andropause for ADRD research$462,923
R21 · FY2024 · AG · contact PI
Investigating the Functional Impact of AD Risk Genes on Neuro-Vascular Interactions$1,603,401
U01 · FY2023 · AG
Metabolic and Hormonal Mechanisms of VCID$355,088
R01 · FY2023 · NS · contact PI
Investigating the Functional Impact of AD Risk Genes on Neuro-Vascular Interactions$93,149
U01 · FY2023 · AG
Investigating the Functional Impact of AD Risk Genes on Neuro-Vascular Interactions$1,635,911
U01 · FY2022 · AG
Metabolic and Hormonal Mechanisms of VCID$355,088
R01 · FY2022 · NS · contact PI
Investigating the Functional Impact of AD Risk Genes on Neuro-Vascular Interactions$121,788
U01 · FY2022 · AG
Investigating the Functional Impact of AD Risk Genes on Neuro-Vascular Interactions$31,078
U01 · FY2022 · AG
Investigating the Functional Impact of AD Risk Genes on Neuro-Vascular Interactions$1,658,307
U01 · FY2021 · AG
Metabolic and Hormonal Mechanisms of VCID$355,088
R01 · FY2021 · NS · contact PI
Metabolic and Hormonal Mechanisms of VCID$360,951
R01 · FY2020 · NS · contact PI
Metabolic and Hormonal Mechanisms of VCID$376,350
R01 · FY2019 · NS · contact PI
Endothelial Aromatase in Sex-Specific Cerebrovascular Dysfunction After Ischemia$56,042
F32 · FY2015 · NS · contact PI
Endothelial Aromatase in Sex-Specific Cerebrovascular Dysfunction After Ischemia$36,213
F32 · FY2014 · NS · contact PI
Endothelial Aromatase in Sex-Specific Cerebrovascular Dysfunction After Ischemia$17,069
F32 · FY2014 · NS · contact PI
Endothelial Aromatase in Sex-Specific Cerebrovascular Dysfunction After Ischemia$49,214
F32 · FY2012 · NS · contact PI